Sterling Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.41M | Buy |
54,509
+3,432
| +7% | +$592K | 0.13% | 104 |
|
|
2025
Q1 | $7.96M | Sell |
51,077
-5,773
| -10% | -$900K | 0.12% | 104 |
|
|
2024
Q4 | $7.83M | Buy |
56,850
+9,065
| +19% | +$1.25M | 0.11% | 120 |
|
|
2024
Q3 | $7.13M | Buy |
+47,785
| New | +$7.13M | 0.09% | 148 |
|
|
2019
Q3 | $5.84M | Buy |
60,580
+5,830
| +11% | +$562K | 0.06% | 228 |
|
|
2019
Q2 | $6.3M | Buy |
54,750
+12,790
| +30% | +$1.47M | 0.06% | 228 |
|
|
2019
Q1 | $4.94M | Buy |
+41,960
| New | +$4.94M | 0.05% | 244 |
|
|
2015
Q2 | – | Sell |
-19,452
| Closed | -$337K | – | 879 |
|
|
2015
Q1 | $337K | Buy |
+19,452
| New | +$337K | ﹤0.01% | 768 |
|